Vetter invests $100m to keep filling services ahead of the game
Vetter says plans for a $100m (€74m) expansion are driven by continued growth in the biopharma industry and keep the firm one step “ahead of the curve.”
Vetter says plans for a $100m (€74m) expansion are driven by continued growth in the biopharma industry and keep the firm one step “ahead of the curve.”
Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.
Lanxess backed enzyme and fine chemicals producer evocatal has moved to a new HQ, beefed up production capacity and is on the look out for new scientific staff.
In a move that could be a sign of a changing tide in India, the Ministry of Health and Family Welfare said the government will invest almost $3bn (€2.2bn) to add hundreds of new inspectors for drug manufacturers and other oversight initiatives that could...
The US FDA has updated its list of activities during the Government shutdown and says it is unable to accept new fee-based regulatory submissions until the shutdown is over.